In 1995, while at Harvard Business School, David Perry founded Virogen, a biotechnology company focused on diagnostics.
[5] While at Virogen, he felt that scientists spent a lot of time in procuring life sciences products through conventional catalog ordering.
It is a B2B marketplace focusing on the life-sciences industry and sells laboratory chemicals and other scientific equipments online.
[6][7][8] In the same year, he also created the parent company of Chemdex, called Ventro Corporation which was later sold to Nexprise.
The biopharmaceutical company is focused on developing novel small-molecule therapeutics to treat infectious and inflammatory diseases.